(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide,
354825, BMS,
BMS 354825,
BMS-354825,
BMS354825,
dasatinib,
N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide,
Sprycel,
Dasatinib monohydrate,
863127-77-9,
Dasatinib hydrate,
BMS 35482503,
dasatinib.H2O,
UNII-RBZ1571X5H,
Dasatinib (monohydrate),
BMS-354825 Monohydrate,
RBZ1571X5H,
MFCD08704581,
AK-64677,
BMS 354825-03,
Dasatinib (USAN),
C22H26ClN7O2S,
N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide hydrate,
N-(2-chloro-6-methylphenyl)-2-((6-(4-(2- hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide hydrate,
N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide--water (1/1),
N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide hydrate,
BMS-354825-03,
dastinib,
dasatinib(tinibs),
Dasatinib [USAN:INN:BAN:JAN],
dasatinib-monohydrate,
SPRYCEL (TN),
Dasatinib hydrate (JAN),
C22H28ClN7O3S,
SCHEMBL290515,
CHEBI:70839,
CTK8F1275,
DTXSID50235486,
s104,
XHXFZZNHDVTMLI-UHFFFAOYSA-N,
HMS3264K15,
BCP09727,
KS-00000OU6,
ABP000240,
ABP001101,
RS0098,
s7782,
AKOS015855318,
AN-5488,
GS-4248,
RL05333,
RTC-070768,
SB17285,
AX8213871,
TC-070768,
B5954,
FT-0083631,
FT-0651515,
ST24024716,
Z1754,
A16320,
D06414,
J10239,
962D498,
A841605,
C-23654,
I01-1226,
I06-1712,
5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-, monohydrate,
5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-, hydrate (1:1),
N-(2-chloranyl-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide hydrate,
N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide hydrate,
N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide hydrate,
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide hydrate,
n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide monohydrate,
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide,hydrate,
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;hydrate,
Dasatinib,
Sprycel,
Dasatinib [USAN],
cc-335,
863127-77-9 (hydrate),
BMS354825,
ACN-034379,
CID11540687,
CID 11540687,
2163H,
Dasatinib monohydrate, 99% - 250MG 250mg,
302962-49-8,